ORLY
66
4
AMT
45
2
NEE
59
5
AVY
54
-4
AVB
67
2
SLG
64
-2
STX
55
-2
GILD
54
3
TAP
63
2
NWSA
63
-4
HCP
62
-8
SRE
45
-9
CF
56
3
O
24
2
AES
41
-2
HSIC
60
-2
MLM
58
-2
HCA
48
2
BEN
48
-4
LYB
41
-2
ORLY
66
4
AMT
45
2
NEE
59
5
AVY
54
-4
AVB
67
2
SLG
64
-2
STX
55
-2
GILD
54
3
TAP
63
2
NWSA
63
-4
HCP
62
-8
SRE
45
-9
CF
56
3
O
24
2
AES
41
-2
HSIC
60
-2
MLM
58
-2
HCA
48
2
BEN
48
-4
LYB
41
-2
Financhill
Back

Frontier Group Holdings Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
24

ULCC
Frontier Group Holdings

Last Price:
5.57
Seasonality Move:
18.06%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
130.47
Seasonality Move:
14.88%
Sell
24
Frontier Group Holdings (ULCC) is a Sell

Is Frontier Group Holdings a Buy, Sell or Hold?

  • The current Frontier Group Holdings [ULCC] share price is $5.57. The Score for ULCC is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • ULCC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ULCC Stock Price Chart

What is Frontier Group Holdings's stock price today?

  • The Frontier Group Holdings share price today is $5.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ULCC is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

ULCC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 42.54 Sell
Chaikin Money Flow: -578459 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.67 - 6.81) Sell
Bollinger Bands (100): (3.52 - 6) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

ULCC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.71 Sell
20-day SMA: 6.09 Sell
50-day SMA: 5.82 Sell
200-day SMA: 5.6 Sell
8-day EMA: 5.76 Sell
20-day EMA: 5.98 Sell
50-day EMA: 5.73 Sell
200-day EMA: 5.5 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Frontier Group Holdings Earnings Growth & ULCC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $0.48 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Frontier Group Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):